当前位置:首页 - 行情中心 - 京新药业(002020) - 财务分析

京新药业

(002020)

  

流通市值:132.85亿  总市值:158.00亿
流通股本:7.24亿   总股本:8.61亿

京新药业(002020)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润3.92亿元,每股收益0.46元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益549614.73万元,未分配利润300040.70万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产791191.51万元,负债241576.77万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入2,016,542,750.22956,068,676.244,158,550,673.093,208,743,897.71
营业总成本1,599,932,166.01785,814,459.843,369,944,245.482,608,110,283.39
其他经营收益
营业利润450,138,341.44193,194,174.6843,605,995.2671,815,265.63
利润总额450,261,320.86193,215,939.31843,979,875.65676,464,298.28
净利润392,203,288.29165,381,300.92719,126,111.66580,559,428.63
每股收益
其他综合收益-336,679.07-93,589.79709,602.25206,930.55
综合收益总额391,866,609.22165,287,711.13719,835,713.91580,766,359.18
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计2,810,717,832.032,719,920,055.312,904,776,219.942,910,144,085.66
非流动资产:
非流动资产合计5,101,197,229.645,266,649,360.945,574,536,998.665,672,840,299.49
资产总计7,911,915,061.677,986,569,416.258,479,313,218.68,582,984,385.15
流动负债:
流动负债合计2,060,726,893.661,910,928,463.822,134,519,745.352,362,726,673.03
非流动负债:
非流动负债合计355,040,836.29351,989,648.39343,249,680.34360,398,609.16
负债合计2,415,767,729.952,262,918,112.212,477,769,425.692,723,125,282.19
所有者权益(或股东权益):
归属于母公司股东权益合计5,463,484,498.345,689,530,119.195,969,508,653.975,829,285,072.07
股东权益合计5,496,147,331.725,723,651,304.046,001,543,792.915,859,859,102.96
负债和股东权益合计7,911,915,061.677,986,569,416.258,479,313,218.68,582,984,385.15
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,949,788,386.33958,581,127.834,018,352,855.93,064,821,115.55
经营活动现金流出小计1,556,879,962.08795,688,384.133,292,191,485.092,452,127,902.62
经营活动产生的现金流量净额392,908,424.25162,892,743.7726,161,370.81612,693,212.93
投资活动产生的现金流量:
投资活动现金流入小计1,594,511,975.961,097,601,857.614,168,216,721.753,277,371,692.31
投资活动现金流出小计961,922,973.01627,128,113.975,606,078,735.874,805,616,860.45
投资活动产生的现金流量净额632,589,002.95470,473,743.64-1,437,862,014.12-1,528,245,168.14
筹资活动产生的现金流量:
筹资活动现金流入小计283,499,548.9589,356,633.35738,862,372.18569,554,941.68
筹资活动现金流出小计1,191,858,989.07628,311,014.691,019,025,287.25725,434,541.85
筹资活动产生的现金流量净额-908,359,440.12-538,954,381.34-280,162,915.07-155,879,600.17
汇率变动对现金及现金等价物的影响202,617.314,003.552,990,123.33-400,802.79
现金及现金等价物净增加额117,340,604.3994,416,109.55-988,873,435.05-1,071,832,358.17
期末现金及现金等价物余额404,485,537.09381,561,042.25287,144,932.7204,186,009.58
补充资料:
现金及现金等价物的净增加额117,340,604.39--988,873,435.05-
最新报告期:2025-09-08
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中银证券刘恩阳1.001.101.202025-09-08
西部证券李梦园0.931.091.232025-09-07
平安证券叶寅,韩盟盟0.961.101.282025-09-04
东方证券伍云飞0.951.101.252025-09-03
光大证券张瀚予,王明瑞0.911.121.222025-09-01
TOP↑